IQV
IQVIA insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$266.09
+29.8% over 12 months
Share price and insider trades
IQV closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$51.4M
Insiders buying0
Insiders selling6
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 IQVIA insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $51.4M. 0 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 39 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 4SEC | James G. BerkshireSee Remarks | Sell | 2,668 | $261.33 | $697K | +1.8% | — |
| Aug 4SEC | W Richard StaubSee Remarks | Sell | 5,500 | $232.68 | $1.3M | +14.4% | — |
| Aug 4SEC | Bhavik PatelSee Remarks | Sell | 1,855 | $235.27 | $436K | +13.1% | — |
| Jul 31SEC | Ari BousbibSee Remarks | Sell | 53,191 | $244.78 | $13.0M | +8.7% | — |
| Jul 31SEC | Ari BousbibSee Remarks | Sell | 44,039 | $246.08 | $10.8M | +8.1% | — |
| Jul 31SEC | Eric SherbetSee Remarks | Sell | 5,000 | $249.16 | $1.2M | +6.8% | — |
| Jul 31SEC | Ari BousbibSee Remarks | Sell | 4,584 | $246.85 | $1.1M | +7.8% | — |
| Jul 31SEC | Ari BousbibSee Remarks | Sell | 4,465 | $247.10 | $1.1M | +7.7% | — |
| Jul 31SEC | Keriann CherofskySee Remarks | Sell | 558 | $245.21 | $137K | +8.5% | — |
| Dec 19SEC | Ari BousbibSee Remarks | Sell | 36,564 | $222.43 | $8.1M | +19.6% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 26,128 | $221.31 | $5.8M | +20.2% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 13,741 | $219.29 | $3.0M | +21.3% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 7,315 | $218.32 | $1.6M | +21.9% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 4,600 | $220.11 | $1.0M | +20.9% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 3,973 | $221.97 | $882K | +19.9% | — |
| Oct 31SEC | Eric SherbetSee Remarks | Sell | 4,000 | $219.70 | $879K | +21.1% | — |
| Oct 31SEC | Ari BousbibSee Remarks | Sell | 800 | $217.58 | $174K | +22.3% | — |
Insiders at IQVIA
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ari BousbibSee Remarks | — | $46.7M | Jul 31, 2026 | — |
| Eric SherbetSee Remarks | — | $2.1M | Jul 31, 2026 | — |
| W Richard StaubSee Remarks | — | $1.3M | Aug 4, 2026 | — |
| James G. BerkshireSee Remarks | — | $697K | Sep 4, 2026 | — |
| Bhavik PatelSee Remarks | — | $436K | Aug 4, 2026 | — |
| Keriann CherofskySee Remarks | — | $137K | Jul 31, 2026 | — |
| Carol BurtDirector | — | — | Apr 27, 2026 | — |
| John G DanhaklDirector | — | — | Apr 27, 2026 | — |
| Colleen A GogginsDirector | — | — | Apr 27, 2026 | — |
| John M LeonardDirector | — | — | Apr 27, 2026 | — |
| Michael J. FedockSee Remarks | — | — | Feb 17, 2026 | — |
| Bernd HaasSee Remarks | — | — | Feb 17, 2026 | — |
| Ronald E BruehlmanSee Remarks | — | — | Feb 10, 2026 | — |
| Alistair GrenfellSee Remarks | — | — | Feb 10, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about IQV insiders
Are IQVIA insiders buying IQV stock?
In the past 12 months, 0 insiders reported open-market purchases of IQV worth $0.
Are IQVIA insiders selling IQV stock?
6 insiders reported sales worth $51.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.